The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers
Abstract Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, lacking effective therapy. Many TNBCs show remarkable response to carboplatin-based chemotherapy, but often develop resistance over time. With increasing use of carboplatin in the clinic, there is a pressing...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/23a5f34fef334ff789f85c69f707a9be |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!